• OPEN AN ACCOUNT
Indian Indices
Sensex
83,919.71 897.96
( 1.08%)
Global Indices
Nasdaq
48,502.41 -615.65
(-1.25%)
Dow Jones
6,987.82 -209.01
(-2.90%)
Hang Seng
56,657.02 -2,787.19
(-4.69%)
Nikkei 225
10,369.59 -83.09
(-0.79%)
Forex
USD-INR
93.34 -0.08
(-0.09%)
EUR-INR
102.47 -0.06
(-0.06%)
GBP-INR
122.55 -0.48
(-0.39%)
JPY-INR
0.58 0.00
(-0.32%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
97.3802066
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
129.56
452298.64
EPS(TTM)
Face Value()
Div & Yield %
14.55
1
0.85
 

Mphasis consolidated net profit rises 19.63% in the September 2026 quarter
Nov 06,2026
Net profit of Mphasis rose 19.63% to Rs 561.13 crore in the quarter ended September 2026 as against Rs 469.07 crore during the previous quarter ended September 2025. Sales rose 17.40% to Rs 4580.93 crore in the quarter ended September 2026 as against Rs 3901.91 crore during the previous quarter ended September 2025.

ParticularsQuarter Ended
Sep. 2026Sep. 2025% Var.
Sales4580.933901.91 17
OPM %18.1018.49 -
PBDT921.17752.49 22
PBT767.57624.78 23
NP561.13469.07 20